1. Selective heart rate reduction with ivabradine slows ischaemia-induced electrophysiological changes and reduces ischaemia–reperfusion-induced ventricular arrhythmias
- Author
-
I. T. Shadi, Nicholas S. Peters, Alexander R. Lyon, and Fu Siong Ng
- Subjects
Male ,medicine.medical_specialty ,Ischaemia–reperfusion ,Myocardial Ischemia ,Ischemia ,Myocardial Reperfusion Injury ,030204 cardiovascular system & hematology ,Rats, Sprague-Dawley ,03 medical and health sciences ,0302 clinical medicine ,Bolus (medicine) ,Ventricular arrhythmias ,Heart Rate ,Internal medicine ,Heart rate ,medicine ,Animals ,Ivabradine ,Artery occlusion ,cardiovascular diseases ,Heart rate reduction ,Molecular Biology ,030304 developmental biology ,0303 health sciences ,business.industry ,Arrhythmias, Cardiac ,Benzazepines ,medicine.disease ,Rats ,3. Good health ,Anesthesia ,Ventricular Fibrillation ,Ventricular fibrillation ,Cardiology ,Original Article ,Reperfusion arrhythmias ,business ,Cardiology and Cardiovascular Medicine ,Anti-Arrhythmia Agents ,Perfusion ,medicine.drug - Abstract
Heart rates during ischaemia and reperfusion are possible determinants of reperfusion arrhythmias. We used ivabradine, a selective If current inhibitor, to assess the effects of heart rate reduction (HRR) during ischaemia–reperfusion on reperfusion ventricular arrhythmias and assessed potential anti-arrhythmic mechanisms by optical mapping. Five groups of rat hearts were subjected to regional ischaemia by left anterior descending artery occlusion for 8 min followed by 10 min of reperfusion: (1) Control n = 10; (2) 1 μM of ivabradine perfusion n = 10; (3) 1 μM of ivabradine + 5 Hz atrial pacing throughout ischaemia–reperfusion n = 5; (4) 1 μM of ivabradine + 5 Hz pacing only at reperfusion; (5) 100 μM of ivabradine was used as a 1 ml bolus upon reperfusion. For optical mapping, 10 hearts (ivabradine n = 5; 5 Hz pacing n = 5) were subjected to global ischaemia whilst transmembrane voltage transients were recorded. Epicardial activation was mapped, and the rate of development of ischaemia-induced electrophysiological changes was assessed. HRR observed in the ivabradine group during both ischaemia (195 ± 11 bpm vs. control 272 ± 14 bpm, p, Highlights ► Ivabradine treatment reduced the incidence of reperfusion ventricular arrhythmia. ► The anti-arrhythmic effects of ivabradine were due to heart rate reduction. ► Mean heart rate during ischaemia is a determinant of reperfusion arrhythmias. ► Heart rate reduction delayed onset of ischaemia-induced electrophysiological changes. ► Selective heart rate lowering is a potential anti-arrhythmic therapeutic strategy.
- Published
- 2013
- Full Text
- View/download PDF